TN MDs challenging gender ideology in medicine. Examining the evidence, educating professionals & public, legislative advocacy. Not personalized medical advice.
Every single systematic review that has examined the evidence for paediatric gender medicine thus far has found it to be low to very low quality.
Then along came a review out of Utah that identifies as a systematic review but is nothing of the sort.
But because facts don’t matter to proponents of paediatric gender medicine, the fake systematic review is now being cited as proof that this mad medical experiment is supported by evidence.
Excellent analysis of all the flaws, inconsistencies, and failures of the Utah review by Zhenya Abbruzzese of @segm_ebm with the brilliant @LeorSapir
The providers are lying and any cursory review of the data will show that in the last ten years tens of thousands of kids, at a minimum, have been surgically and hormonally harmed by gender medicine.
"An Open Letter to the Surgeon Who Removed My Breasts.
I have lived every day for the last seven years with the physical and psychological wreckage you left behind. When I was fourteen years old, you took a scalpel to my healthy body and amputated my breasts.
I didn’t have the capacity to understand the permanence of what you were doing to me."
A heart rending read by Claire @burnyourbinder We are immensely grateful she chose to courageously share her vulnerability with us.
https://t.co/0nh0rwMtEQ
Endocrinologist @real_dr_roy says doctors must STOP pretending detransitioners don’t exist.@nypost@ClevelandClinic and @TexasChildrens now agree to care (to address investigations).
Doc’s right: such correction is due to outside pressure. Doctors aren’t correcting ourselves.
The word doing the heavy lifting here is 'INVESTMENT', which is defined as "the action or process of investing money for profit or material result". Billionaires like "Jennifer" Pritzker and trans activists like Zohran Mamdani @NYCMayor do not see the systematic dissociation of human sex using trans propaganda as kindness to the confused and vulnerable, but a clever way to gain returns on "gender-affirming healthcare" for hard, cold cash. @bjportraits
Excellent new article highlighting what many of us have seen with our own children:
"Five overlapping retrospective pathways to transition emerged: (1) Neurocognitive conditions; (2) Prior sexual abuse and dissociation; (3) Social contagion and digital amplification; (4) Ego-dystonic sexuality; and (5) Fear of emerging sexuality and extreme sexual stereotyping. The new identity was frequently accompanied by initial validation euphoria and maintained by sunk-cost psychology. Upon detransitioning, despite navigating complex post-transition medical sequelae and grief, some participants reported profound relief. Within this cohort, transition appeared to be at least partially an attempt to decrease preexisting psychosocial distress. These findings support the critical necessity of comprehensive psychiatric evaluations to establish a thorough developmental timeline of adolescent distress and comorbid conditions—prior to medical interventions. The findings highlight the clinical risks of diagnostic overshadowing."
https://t.co/fsFl6yfLMM
HOW USAID PUSHED GENDER IDEOLOGY ABROAD, an overview
The United States Agency for International Development (USAID)'s systematic integration of gender ideology, meaning policies promoting "transgender inclusion", "gender identity" concepts, "gender-affirming" medical interventions, and broader "LGBTQI+" advocacy into foreign development aid, shows bureaucratic overreach that subordinated evidence-based priorities, fiscal responsibility, and cultural sensitivity to ideological goals in resource-scarce nations. We looked into how this started and the progressive scaling up.
While the President's Emergency Plan for AIDS Relief (PEPFAR), launched in 2003 under President George W. Bush, has undeniably saved millions of lives through targeted HIV prevention, treatment, and care internationally, the layering of gender identity ideology onto charitable programs and standalone grants created legitimate concerns about waste, effectiveness, and the export of Western medical controversies, particularly around "gender-affirming healthcare".
Dedicated "LGBTQI+" aid was modest initially, but ballooned under the Biden administration from approximately 6 million United States dollars (USD) in fiscal year (FY) 2021 to 25 million USD in FY 2024, inviting intense congressional scrutiny and backlash when the 2025 Trump administration paused nearly all foreign aid. The mission creep undermined trust in proven HIV work, diverted funds from universal basics like clean water, nutrition, maternal health, and routine vaccinations.
TIMELINE OF USAID'S SHIFT INTO GENDER IDEOLOGY FUNDING
- Pre-2011 (purely health-focused under PEPFAR):
PEPFAR, initiated in 2003, emphasized HIV/acquired immunodeficiency syndrome (AIDS) prevention, treatment, and care for "key populations". Initially focused on men who have sex with men, "transgender individuals" were later added in a limited public-health context. This era involved no explicit transgender advocacy, gender-identity policies, or puberty blocker elements, it was framed strictly as evidence-based global health aid with measurable outcomes in lives saved.
- 2011: Obama Presidential Memorandum triggers policy changes
In December 2011, President Barack Obama issued a presidential memorandum directing all U.S. agencies, including USAID, to "promote and protect the human rights of lesbian, gay, bisexual, and transgender persons abroad". This top-down mandate laid the groundwork for embedding "gender ideology" into development work, but there were no immediate funding shifts or change in medical intervention guidelines that happened at the time.
- 2014: Formal institutionalization via the LGBT Vision for Action (Obama-era launch)
In June 2014, USAID released its "USAID LGBT Vision for Action: Promoting and Supporting the Inclusion of Lesbian, Gay, Bisexual, and Transgender Individuals" - the agency's first explicit, agency-wide policy. It mandated inclusion of lesbian, gay, bisexual, and "transgender individuals" across all development sectors (civil society building, human rights, health, economic growth, and governance). This marked the systematic start of gender ideology embedding, including the creation of the "LGBTI Global Development Partnership" as a flagship public-private mechanism. Funding at this stage was still modest and primarily non-medical, focused on advocacy and capacity-building rather than direct clinical services.
- 2014–2020 (incremental growth through Obama-to-Trump transition): Grants supported LGBTQI+ civil society organizations (CSOs) and HIV treatment merges via initiatives like the 225 million USD LINKAGES project (a five-year effort starting 2014 that targeted key populations including transgender people for HIV services). The first Trump administration de-emphasized explicit promotion but did not eliminate the structures.
- 2021–2024: Biden-era explosive ramp-up and explicit "gender-affirming" mandates
Dedicated LGBTQI+ resources surged from 6 million USD (FY2021) to 25 million USD (FY2024), positioning USAID as one of the top global donors. In August 2023, USAID issued the "LGBTQI+ Inclusive Development Policy" (an update to the 2014 Vision under Administrator Samantha Power), which required explicit integration of gender identity and expression into EVERY programming sector. PEPFAR HIV targets for pre-exposure prophylaxis and antiretroviral therapy "expanded" to include "transgender populations" as seperate categories. This period saw the first documented grants explicitly referencing "gender-affirming health care."
- 2025 onward: Trump second-term reversals and disruptions
January 2025 executive orders paused nearly all foreign aid for review, explicitly targeting gender ideology promotion, leading to USAID's effective near-dismantling (thousands of contracts terminated, LGBTQI+ website pages scrubbed, and staff layoffs). PEPFAR received limited waivers for core HIV services, but testing and treatment initiations dropped sharply (8.5–31% declines in metrics across some African countries). Trans-led clinics scaled back or closed, and independent modeling projected potential excess HIV infections and deaths, though exact effect remain unclear amid host-country adaptations and other donors filling gaps.
SPECIFICS ON "PUBERTY BLOCKERS" AND DIRECT "GENDER-AFFIRMING CARE"
Puberty blockers appear rarely and narrowly in public USAID records, never as a standalone line item or agency-wide procurement program. The sole prominently documented example is the April 2024 three-year grant (award ASST_NON_72052024FA00001_7200) to Guatemala's Asociación Lambda (a trans-led organization), valued at 2 million USD total with approximately 350,000–746,201 USD obligated/outlaid before the 2025 pauses. The official grant description states the objective was to "strengthen trans-led organizations to deliver gender-affirming health care, advocate for improved quality and access to services, and provide economic empowerment opportunities." Verified fact-checks and https://t.co/hupj4TWEzy records confirm this encompassed hormone therapies," puberty blockers", mental health support, and speech therapy (not limited to surgeries). This involvement is highly questionable: so-called puberty blockers are not Food and Drug Administration (FDA)-approved for "gender dysphoria" (off-label use only), carry documented risks (e.g., compromised bone density, potential impacts on fertility and brain development), and lack robust long-term evidence of net benefit per the Cass Review and subsequent European restrictions. Facilitating them via U.S. taxpayer funds in settings with limited diagnostic/follow-up capacity raises ethical concerns about exporting experimental interventions over proven priorities like childhood malnutrition or infectious disease control. Broader trans-focused grants (via PEPFAR or inclusion programs) emphasized adult HIV services, but may have indirectly enabled puberty blockers/cross-sex hormone access in local clinics without appropriate oversight.
FUNDING BY KEY ORGANIZATIONS AND GRANTS 💵 💵 💵
Funding primarily flowed through public-private partnerships created or amplified by the 2014 LGBT Vision for Action, often routed under HIV, human rights, or economic inclusion umbrellas. Implementing partners (typically US or other western-based NGOs) received core awards before sub-granting to local CSOs, with administrative overhead raising efficiency questions. Key examples include:
- LGBTI Global Development Partnership (launched 2014 alongside the Vision):
Flagship mechanism that awarded over 100 grants to local LGBTQI+ CSOs worldwide and trained more than 1,700 LGBT entrepreneurs/businesses. It operated within broader democracy and human rights budgets and served as the foundational pipeline for later initiatives.
- Multi-Donor LGBTI Global Human Rights Initiative (GHRI, launched ~2019 and running through 2027):
Built directly on the Vision; a multi-year partnership with donors including Sweden's Sida. It supported 225 LGBTQI+ CSOs with emergency aid, violence protection, and advocacy. Primary U.S. implementer: the Astraea Lesbian Foundation for Justice, which received at least 15,328,367 USD (one documented grant).
- Alliance for Global Equality (launched ~2023 as part of the Inclusive Development Policy update): Five-year public-private effort focused on post-COVID recovery, livelihoods, and countering "human rights rollbacks." Lead partner OutRight International received one key grant with 6 million USD obligated (total Alliance-related funding around 22.7 million USD including non-federal sources).
- Notable smaller/indirect grants highlighted in congressional oversight:
3.3 million USD for "being LGBTQ in the Caribbean"
5.5 million USD for LGBTQ causes in Uganda
1.5 million USD for LGBTQ+ job/DEI opportunities in Serbia 3.9 million USD in the Western Balkans
2.5 million USD in Vietnam
32,000 USD for a "transgender comic book" in Peru
47,000 USD for a "transgender opera" in Colombia
100,000 USD for a drag HIV awareness campaign in South Africa.
These often overlapped with PEPFAR's 225 million USD LINKAGES project or general inclusion programming.
CONTROVERSIES AND 2025 TRUMP ADMINISTRATION IMPACT
Congressional Republicans and oversight bodies labeled many expenditures as wasteful cultural imposition in socially conservative regions, arguing they prioritized ideology over measurable development outcomes. In total, the programs created self-reinforcing networks of activist intermediaries that lobbied for sustained funding, often provoking local (and international) backlash without clear proof of superior outcomes versus neutral health aid. The 2025 aid pause triggered immediate real-world consequences: HIV service disruptions in multiple countries, closure or scaling-back of trans-led clinics (e.g., Mitr clinics in India that relied on USAID for "HIV prevention, hormone access, and mental health"), and reported drops in key-population outreach. The ideological add-ons unfortunately created political vulnerability and service fragility - effective HIV results simply do not require entanglement with the concept of "gender ideology".
In conclusion, while framed by trans activists as advancing inclusion and HIV metrics, USAID's gender ideology push, from the 2014 Vision through Biden-era expansions, illustrates how tens of millions in targeted spending can embed harmful social experiments into life-saving aid frameworks, ultimately undermining efficiency and inviting the 2025 reckoning. Developing countries deserved focus on proven, universal basics, not ideological trans activism infiltration and social engineering, ultimately limiting much-needed real international medical aid. After the administration manages to weed out gender ideology and frivolous fringe elements, we hope USAID, founded in 1961, can continue to serve the desperately poor around the world like its original charitable mission, in a manner befitting of its long and heroical medical history.
REFERENCES AND SOURCES:
1. USAID LGBT Vision for Action (2014) launch, Todd Larson role as Senior LGBT Coordinator, and origins in Obama's December 2011 Presidential Memorandum: Obama White House archives (https://t.co/JpuAxBBYzd); U.S. Presidency Project (https://t.co/XIQiKXQino)
2. Guatemala Asociación Lambda grant details (award ASST_NON_72052024FA00001_7200; 2 million USD total, 350,000–746,201 USD outlaid; explicit inclusion of puberty blockers in gender-affirming care): https://t.co/lThjzHmAkw
3. Fact-checks confirming Guatemala grant scope (hormones, puberty blockers, mental health, not solely surgeries): Yahoo/Snopes (https://t.co/6eDUVlSCyR)
4. Dedicated LGBTQI+ funding growth (6 million USD FY2021 to 25 million USD FY2024) and August 2023 LGBTQI+ Inclusive Development Policy: Williams Institute (https://t.co/bd23Blfbg7); OutRight International PDF (https://t.co/Cc03GItVE5)
5. LGBTI Global Development Partnership (over 100 grants, 1,700+ entrepreneurs trained): Obama White House 2016 fact sheet (https://t.co/6dFkyYM8Ro)
6. Multi-Donor LGBTI Global Human Rights Initiative and Astraea Lesbian Foundation for Justice (15,328,367 USD): https://t.co/K0aJ5d6D9K; State Department implementation reports
7. Alliance for Global Equality and OutRight International (6 million USD obligated on one key grant): https://t.co/oEtiir58AB; OutRight press release (https://t.co/84fbvGTtqU)
8. Smaller/indirect grant examples (Caribbean 3.3 million USD, Uganda 5.5 million USD, Peru comic 32,000 USD, Colombia opera 47,000 USD, South Africa drag 100,000 USD, etc.) and PEPFAR/LINKAGES context (225 million USD project): Congressional oversight reports (https://t.co/ZEagAPoqeI); https://t.co/hupj4TWEzy records
9. 2025 aid pauses, PEPFAR disruptions (8.5–31% drops), clinic impacts (e.g., Mitr India), and modeling: Williams Institute EO analysis; OutRight "Defunding Freedom" report (https://t.co/9VVMdJCG8c); White House statements on rescissions
10. Cass Review (2024) on puberty blockers, risks, weak evidence, and European restrictions (Sweden, Finland, Norway, UK): Independent UK review findings (cited in policy shifts)
11. Broader context and C-Fam critiques of "development deep state": https://t.co/eEctTKG6GY; State Department PEPFAR reports
#USAID #charity #genderidentity #genderideology #infiltration #HIV #humanrights #donoharm #socialengineering
He wants his son to be "comfortable in his own skin." That is exactly the opposite of what "gender affirming care" is. "I'm not going to do anything that is going to hurt him." If you affirm your son as a girl that he can never become & consent to his chemical castration, you are in fact hurting him.
Remember when the Cass Review came out, activists said it was full of mistakes & no one should follow it?
The British Medical Assoc. did a review *of the Cass Review*… a meta-review, in response to activist critics
Result: BMA vindicates every one of Cass’ 82 recommendations
We don't need to waste our energy trying to reach the fanatics in the field of "gender affirming care." We don't need to waste our energy trying to reason with the zealots inside WPATH
They're True Believers. They'll never listen.
Our goal should be total merciless destruction.
Why do early data suggest most detransitioners are female?
Simple. Because the social contagion of the 2010s struck predominantly adolescent girls and that cohort is now reaching adulthood and realising they were sacrificed on the altar of trans activism
Here is an new link to a podcast-style conversation featuring Finnish psychiatrist and gender-medicine specialist Rittakerttu Kaltiala. It summarizes her work and her research findings in 19 minutes of audio.
https://t.co/xaVXo9NCdH
Should someone be able to have their healthy legs amputated for reasons of bodily autonomy?
Should someone with anorexia be prescribed “skinny jabs” for bodily autonomy?
Medical ethics *should balance autonomy with beneficence, non-maleficence and justice.
Many on the left have attacked the Cass Review that raised serious concerns over gender identity treatments for children. They often cite opposition of the British Medical Association. Yesterday, the BMA dropped its opposition after reviewing the study... https://t.co/8UNAzOKf6p
Fighting the tenacious grip that the trans industry has on medicine, including the largely successful attempt to stifle debate so far, might be the biggest moral challenge doctors all over the United States and other industrialized nations face today. It's the raging pink, blue & white bull in the china shop, and we can't afford any more broken china, people. It's not just a fad, and it's not going away on its own. Poke it. Come on, just poke it. Then grab it by the horns and put it to pasture so we can clean up shop.